Skip to main content

Table 2 Examples of selection criteria, with each component identified in bold

From: Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events

Two selection criteria (i.e., numerical threshold and participant group):
 Adverse events are reported if they occurred in ≥ 5% of participants in any intervention group.
 Adverse events are reported if they occurred in ≥ 2% of participants receiving gabapentin.
Three selection criteria:
 Adverse events are reported if they occurred in ≥ 2% of participants receiving gabapentin and if they occurred at least twice as frequently in participants receiving gabapentin, compared with participants receiving placebo.